Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species & therapy areas
David Eric Lees(National Institutes of Health Clinical Center), Ruth Roberts(Redx Pharma (United Kingdom)), Steve Horner(AstraZeneca (United Kingdom)), R.D. Callander(AstraZeneca (United Kingdom)), Sally Robinson(AstraZeneca (United Kingdom)), David Ryan(University College Cork)
Cited by 1
Related Papers
Toward the Development of a New Self-Report Alexithymia Scale
|Psychotherapy and Psychosomatics|2010|859
Establishment of porcine and human expanded potential stem cells
|Nature Cell Biology|2019|411
Establishment of mouse expanded potential stem cells
|Nature|2017|308
Toronto Alexithymia Scale: Relationship with Personality and Psychopathology Measures
|Psychotherapy and Psychosomatics|2010|255
Somatosensory evoked potentials during whole body hyperthermia in humans
|Electroencephalography and Clinical Neurophysiology|1981|92